These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24989267)

  • 1. [Expression of CD25 in acute B cell lymphoblastic leukemia and its clinical significance].
    Yang C; Yang LH; Zhang RJ; Ge XY; Wang MF; Ren FG; Zhang YF; Hou YF; Wang YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):634-9. PubMed ID: 24989267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunophenotypic features of bcr/abl fusion transcript-positive B-lineage acute lymphoblast leukemia].
    Li JL; Liu YR; Qin YZ; Chang Y; Fu JY; Wang H; Ruan GR; Chen SS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):142-5. PubMed ID: 12744735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD25 (interleukin-2 receptor alpha chain) in adult acute lymphoblastic leukemia predicts for the presence of BCR/ABL fusion transcripts: results of a preliminary laboratory analysis of ECOG/MRC Intergroup Study E2993. Eastern Cooperative Oncology Group/Medical Research Council.
    Paietta E; Racevskis J; Neuberg D; Rowe JM; Goldstone AH; Wiernik PH
    Leukemia; 1997 Nov; 11(11):1887-90. PubMed ID: 9369422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD66c and CD25 in acute lymphoblastic leukemia as a predictor of the presence of BCR/ABL rearrangement.
    Owaidah TM; Rawas FI; Al Khayatt MF; Elkum NB
    Hematol Oncol Stem Cell Ther; 2008; 1(1):34-7. PubMed ID: 20063526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation].
    Qin YZ; Li JL; Zhu HH; Ruan GR; Li LD; Zhang Y; Xu LP; Liu DH; Liu YR; Huang XJ; Chen SS; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):511-4. PubMed ID: 17172121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of effective antigen combinations in childhood B lineage acute lymphoblastic leukemia].
    Liu Y; Tang JY; Xu C; Gu LJ; Xue HL; Chen J; Pan C; Dong L; Zhou M
    Zhonghua Er Ke Za Zhi; 2009 May; 47(5):366-70. PubMed ID: 19573409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undifferentiated immunophenotypes and not expression of BCR-ABL can be associated in adult Mestizo Mexican patients with ALL.
    Vázquez-Franco JE; Reyes-Maldonado E; Montiel-Cervantes LA; Lezama RA
    Rev Invest Clin; 2012; 64(1):32-9. PubMed ID: 22690527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of CD34(+)CD38(+) and CD34(+)CD38(low/-) subgroups in bone marrow of patients with B lymphoblastic leukemia].
    Hao L; Liu YR; Wang YZ; Chang Y; Qin YZ; Li JL; Li LD; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):801-5. PubMed ID: 22931632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia.
    Corrente F; Bellesi S; Metafuni E; Puggioni PL; Marietti S; Ciminello AM; Za T; Sorà F; Fianchi L; Sica S; De Stefano V; Chiusolo P
    Cytometry B Clin Cytom; 2018 May; 94(3):468-476. PubMed ID: 29220871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
    Paschka P; Müller MC; Merx K; Kreil S; Schoch C; Lahaye T; Weisser A; Petzold A; König H; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
    Leukemia; 2003 Sep; 17(9):1687-94. PubMed ID: 12970765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The monitoring of BCR-ABL mRNA by reverse transcription PCR in patients undergoing allogeneic bone marrow transplantation for acute lymphoblastic leukemia with a positive Philadelphia chromosome].
    Román J; Castillejo JA; Jiménez A; Maldonado J; Torres A
    Med Clin (Barc); 1999 Dec; 113(20):779-82. PubMed ID: 10680143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous occurrence of ETV6-RUNX1 and BCR-ABL1 (e1a2) transcripts in a child with B-cell acute lymphoblastic leukemia.
    Balatzenko G; Guenova M; Kalinova I; Belcheva M; Hristozova H; Kaleva V
    Cancer Genet; 2013 Mar; 206(3):97-101. PubMed ID: 23491079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A late-appearing Philadelphia chromosome in acute lymphoblastic leukemia confirmed by expression of BCR-ABL mRNA.
    Tsuchiya H; Migita M; Yamamori S; Kaneko Y; Adachi N; Nakamura T; Nobukuni Y; el-Sonbaty SS; Matsuda I
    Leukemia; 1995 Oct; 9(10):1689-93. PubMed ID: 7564511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene of DNA-dependent protein kinase catalylic subunit in chronic myeloid leukemia].
    Luo J; Peng ZG; Chen Y; Lai YR; Lu YY; Song SJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):248-52. PubMed ID: 17493325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of minimal residual disease in patients with e1a2 BCR-ABL-positive acute lymphoblastic leukemia using a real-time RT-PCR assay.
    Yokota H; Tsuno NH; Tanaka Y; Fukui T; Kitamura K; Hirai H; Osumi K; Itou N; Satoh H; Okabe M; Nakahara K
    Leukemia; 2002 Jun; 16(6):1167-75. PubMed ID: 12040449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
    Primo D; Flores J; Quijano S; Sanchez ML; Sarasquete ME; del Pino-Montes J; Gaarder PI; Gonzalez M; Orfao A
    Br J Haematol; 2006 Oct; 135(1):43-51. PubMed ID: 16939497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of bcr-abl fusion transcripts following bone marrow transplantation for Philadelphia chromosome-positive leukemia.
    Kohler S; Galili N; Sklar JL; Donlon TA; Blume KG; Cleary ML
    Leukemia; 1990 Aug; 4(8):541-7. PubMed ID: 2201832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of beta-Catenin Gene in CML and its relationship with bcr/abl].
    Li ZJ; Qiu LG; Li X; Mai YJ; Wang GR; Yu Z; Wang YF; Li CH; Li Q
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):931-5. PubMed ID: 17956664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
    Fujie H; Tsuchiya S; Morita S; Itano M; Yambe T; Ohasi Y; Minegishi N; Minegishi M; Satou T; Konno T
    Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial minimal residual disease (MRD) analysis as a predictor of response duration in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) during imatinib treatment.
    Scheuring UJ; Pfeifer H; Wassmann B; Brück P; Gehrke B; Petershofen EK; Gschaidmeier H; Hoelzer D; Ottmann OG
    Leukemia; 2003 Sep; 17(9):1700-6. PubMed ID: 12970767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.